Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Atricure Inc (ATRC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,132,040
  • Shares Outstanding, K 38,623
  • Annual Sales, $ 201,630 K
  • Annual Income, $ -21,140 K
  • 60-Month Beta 0.29
  • Price/Sales 5.61
  • Price/Cash Flow N/A
  • Price/Book 4.73

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate -0.18
  • Number of Estimates 5
  • High Estimate -0.16
  • Low Estimate -0.20
  • Prior Year -0.19
  • Growth Rate Est. (year over year) +5.26%

Price Performance

See More
Period Period Low Period High Performance
1-Month
27.60 +6.92%
on 04/25/19
30.84 -4.33%
on 05/06/19
+1.55 (+5.54%)
since 04/24/19
3-Month
26.11 +13.02%
on 03/28/19
33.92 -13.00%
on 02/27/19
-3.69 (-11.11%)
since 02/22/19
52-Week
23.61 +24.99%
on 05/25/18
36.49 -19.13%
on 10/01/18
+5.68 (+23.84%)
since 05/24/18

Most Recent Stories

More News
AtriCure Reports First Quarter 2019 Financial Results

--U.S. revenue of $43.0 million - an increase of 11.9% year over year

ATRC : 29.51 (+0.68%)
AtriCure Announces First Patient Enrollment in the DEEP IDE Trial Restart

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatment for atrial fibrillation (Afib) and left atrial appendage management, today announced the restart of the Dual Epicardial...

ATRC : 29.51 (+0.68%)
Nevro Corp is Among the Companies in the Health Care Equipment Industry with the Best Relative Performance (NVRO , RMD , ATRC , EW , VAR )

We looked at the Health Care Equipment industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We...

NVRO : 59.05 (+1.27%)
RMD : 113.89 (+1.02%)
ATRC : 29.51 (+0.68%)
Top 5 Companies in the Health Care Equipment Industry with the Best Relative Performance (HRC , ATRC , EW , DXCM , NUVA )

Here are the top 5 stocks in the Health Care Equipment industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

EW : 169.38 (-0.35%)
HRC : 97.31 (+0.77%)
ATRC : 29.51 (+0.68%)
Dexcom is Among the Companies in the Health Care Equipment Industry with the Best Relative Performance (DXCM , CRY , ATRC , BDX , ISRG )

Below are the top five companies in the Health Care Equipment industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that...

ATRC : 29.51 (+0.68%)
CRY : 28.33 (+1.25%)
DXCM : 118.97 (+3.94%)
AtriCure to Announce First Quarter 2019 Financial Results

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that it will release...

ATRC : 29.51 (+0.68%)
SmarTrend Watching for Potential Pullback in Shares of Atricure Inc After 3.73% Gain

Atricure Inc (NASDAQ:ATRC) traded in a range yesterday that spanned from a low of $27.81 to a high of $28.48. Yesterday, the shares gained 3.7%, which took the trading range above the 3-day high of $27.71...

ATRC : 29.51 (+0.68%)
AtriCure to Present at the Needham & Company's 18th Annual Healthcare Conference

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage management, today announced that it will present...

ATRC : 29.51 (+0.68%)
Factors of Influence in 2019, Key Indicators and Opportunity within Expedia Group, Lumentum, Patterson Companies, Allscripts Healthcare Solutions, AtriCure, and Biohaven Pharmaceutical Holding -- New Research Emphasizes Economic Growth

In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Expedia Group, Inc. (NASDAQ:EXPE),...

BHVN : 61.83 (+1.84%)
PDCO : 22.07 (+1.01%)
EXPE : 115.92 (-0.45%)
MDRX : 10.19 (+1.49%)
ATRC : 29.51 (+0.68%)
LITE : 44.41 (+0.59%)
Axonics(R) Appoints Michael H. Carrel to its Board of Directors

Axonics Modulation Technologies, Inc. (NASDAQ: AXNX) a medical technology company focused on the development and commercialization of novel implantable Sacral Neuromodulation ("SNM") devicesfor...

ATRC : 29.51 (+0.68%)
AXNX : 31.60 (+4.39%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum. Long term indicators fully support a continuation of the trend.

See More Share

Trade ATRC with:

Business Summary

AtriCure, Inc. is a medical device company focused on developing, manufacturing and selling innovative surgical devices to create precise lesions, or scars, in soft tissues. Medical journals have described the adoption by leading cardiothoracic surgeons of the AtriCure, Inc. bipolar ablation system as...

See More

Key Turning Points

2nd Resistance Point 30.12
1st Resistance Point 29.82
Last Price 29.51
1st Support Level 29.24
2nd Support Level 28.97

See More

52-Week High 36.49
Fibonacci 61.8% 31.57
Fibonacci 50% 30.05
Last Price 29.51
Fibonacci 38.2% 28.53
52-Week Low 23.61

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar